Literature DB >> 3943731

Low-energy long-exposure laser therapy in the management of choroidal melanoma.

W S Foulds, B E Damato.   

Abstract

Low-energy (0.2-0.4 W) long-exposure (10-30 s) argon green and krypton red laser applications were used in the treatment of 29 selected choroidal melanomas. In 11 cases laser treatment was the only therapy used. In 18 cases laser was used as an adjunct to local surgical resection of the tumour. The technique gives promise of being useful in the management of relatively flat choroidal melanomas of up 4 mm in thickness.

Entities:  

Mesh:

Year:  1986        PMID: 3943731     DOI: 10.1007/bf02144128

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Further progress in the field of light coagulation.

Authors:  G MEYER-SCHWICKERATH
Journal:  Trans Ophthalmol Soc U K       Date:  1957

2.  The preservation of vision by treatment of intraocular tumors with light coagulation.

Authors:  G MEYER-SCHWICKERATH
Journal:  Arch Ophthalmol       Date:  1961-10

3.  Recurrence of malignant melanoma of the choroid seven and eight years after lightcoagulation.

Authors:  J François; M Hanssens; J J De Laey
Journal:  Ophthalmologica       Date:  1971       Impact factor: 3.250

4.  Treatment of malignant choroidal melanomas with photocoagulation. Evaluation of 10-year follow-up data.

Authors:  M H Vogel
Journal:  Am J Ophthalmol       Date:  1972-07       Impact factor: 5.258

  4 in total
  11 in total

1.  Local resection of posterior uveal melanoma.

Authors:  J A Shields
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

2.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

3.  Photocoagulation of raised new vessels by long-duration low-energy argon laser photocoagulation--a preliminary study.

Authors:  S M Zeki; G N Dutton
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

4.  Endoresection of choroidal melanoma.

Authors:  B Damato; C Groenewald; J McGalliard; D Wong
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

5.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

6.  Iatrogenic choroidal neovascularisation following argon laser photocoagulation for choroidal malignant melanoma.

Authors:  Z I Currie; I G Rennie; J F Talbot
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

7.  Subthreshold argon-laser irradiation elicits a pronounced vitreal prostaglandin E2 response.

Authors:  N Naveh; E Bartov; C Weissman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Predictive factors of visual outcome after local resection of choroidal melanoma.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

9.  Combined iodine-125 plaque irradiation and indirect ophthalmoscope laser therapy of choroidal malignant melanomas: comparison with iodine-125 and cobalt-60 plaque radiotherapy alone.

Authors:  J J Augsburger; M Kleineidam; D Mullen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

10.  Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma.

Authors:  J G Journée-de Korver; J A Oosterhuis; H M Kakebeeke-Kemme; D de Wolff-Rouendaal
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.